Viewing Study NCT01637402


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-04-24 @ 12:28 PM
Study NCT ID: NCT01637402
Status: COMPLETED
Last Update Posted: 2020-08-17
First Post: 2012-07-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Sponsor: Terence Friedlander, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CRPC View
None Prostate View
None Cancer View